Search Within

Hematologic Malignancies, Division of

Formats
  1. Meeting Abstract (6372)
  2. Journal Article (5781)
  3. Review (421)
  4. Editorial (196)
  5. Book Section (188)
  6. Research Letter (179)
  7. Guidelines (88)
  8. Conference Paper (65)
  9. Correspondence (62)
  10. Miscellaneous (18)
  11. Book Whole (9)
Groups
  1. Department of Medicine (13278)
  2. Center for Hematologic Malignancies (10612)
  3. GSK Faculty (4482)
  4. Adult Leukemia (3673)
  5. Bone Marrow Transplant (2848)
  6. Lymphoma (2705)

More Groups

People
  1. Sergio Giralt (1069)
  2. Miguel-Angel Perales (943)
  3. Ross Levine (787)
  4. Andrew Zelenetz (784)
  5. Steven Horwitz (669)
  6. Martin Tallman (655)

More People

Years
  1. 2025 (340)
  2. 2024 (823)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3529)
  2. Journal of Clinical Oncology (1233)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (330)
  5. Haematologica (292)
  6. Bone Marrow Transplantation (239)

More Publications

Publishers
  1. American Society of Hematology (3806)
  2. Elsevier Inc. (1530)
  3. American Society of Clinical Oncology (1288)
  4. Nature Publishing Group (1009)
  5. American Association for Cancer Research (641)
  6. Wiley Blackwell (433)

More Publishers

Results (13379)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Validation of flow cytometric measurements of NK cytotoxicity against chromium release assay for use in clinical monitoring of immune function
    Meeting Abstract

    Smith, K.; Heller, G.; Maslak, P.
    Blood (2006)

    Fulltext@MSK | Save
  • Pilot trial of rituximab for the prevention of Epstein Barr virus B cell lymphoproliferative disorder (EBV-LPD) following T cell depleted (TCD) unrela ted or HLA-mismatched related hematopoietic stem cell transplantation
    Meeting Abstract

    Small, T. N.; Kernan, N. A.; Jakubowski, A.; Young, J. W.; Prockop, S.; Perales, M. A.; O'Reilly, R. J.; Papadopoulos, E. B.
    Blood (2006)

    Fulltext@MSK | Save
  • Phase I trial results of PCK3145 in patients (pts) with castrate metastatic prostate cancer (PC) - The US experience
    Meeting Abstract

    Slovin, S. F.; Daigneault, L.; Dulude, H.; Panchal, C.; Richardson, J.; Curley, T.; Delacruz, A.; Fleisher, M.; Morris, M.; Scher, H.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Relative biological effectiveness for efficacy and toxicity in leukemia patients of the alpha-particle emitter, bismuth-213
    Meeting Abstract

    Sgouros, G.; Bolch, W. E.; Shah, A.; Watchman, C. J.; Jurcic, J. G.; Scheinberg, D. A.
    Cancer Biotherapy and Radiopharmaceuticals (2006)

    Fulltext@MSK | Save
  • Psychostimulants for fatigue in prostate cancer
    Meeting Abstract

    Roth, A. J.; Nelson, C. J.; Rosenfeld, B.; O'Shea, N.; Slovin, S.; Scher, H. I.; Breitbart, W.
    Psycho-Oncology (2006)

    Fulltext@MSK | Save
  • Randomized controlled trial testing methylphenidate as treatment for fatigue in men with prostate cancer
    Meeting Abstract

    Roth, A. J.; Nelson, C. J.; Rosenfeld, B.; O'Shea, N.; Slovin, S.
    Psycho-Oncology (2006)

    Fulltext@MSK | Save
  • Concordance with national comprehensive cancer network (NCCN) clinical practice guidelines (CPGs): A quality of care tool for newly diagnosed patients (pts) with mantle cell lymphoma (MCL)
    Meeting Abstract

    Rodriguez, M. A.; ter Veer, A.; Nademanee, A.; Niland, J.; Lepisto, E.; Kho, M.; LaCasce, A.; Weeks, J. C.; Czuczman, M.; Millenson, M.; more...
    Blood (2006)

    Fulltext@MSK | Save
  • Long term clinical benefit of lenalidomide (Revlimid) treatment in patients with myelodysplastic syndrome without del 5q cytogenetic abnormalities
    Meeting Abstract

    Raza, A.; Reeves, J. E.; Feldman, E. J.; Deeg, H. J.; Dreisbach, L.; Schiffer, C. A.; Shammo, J. M.; Klimek, V. M.; Greenberg, P. L.; Bennett, J. M.; more...
    Blood (2006)

    Fulltext@MSK | Save
  • The Stanford experience with utilizing the new WHO classification of cutaneous lymphomas for cutaneous B cell lymphoma
    Meeting Abstract

    Reddy, S.; Kohler, S.; Horwitz, S.; Sutherland, K.; Hoppe, R. T.; Kim, Y. H.
    Journal of Investigative Dermatology (2006)

    Fulltext@MSK | Save
  • Increased dose intensity of SGN-33, a humanized monoclonal antibody targeting CD33, is active and well-tolerated in patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS)
    Meeting Abstract

    Raza, A.; Jurcic, J. G.; Roboz, G. J.; Stephenson, J. J.; Rarick, M. U.; Wood, B. L.; Grove, L. E.; Sieyers, E. L.; Drachman, J. G.
    Blood (2006)

    Fulltext@MSK | Save